FDA Approved

Get Semaglutide Online — From $179/Month

Real Semaglutide prescribed by licensed US clinicians. ~15% body weight body weight on average. The most-prescribed GLP-1 medication. Active ingredient in Ozempic, Wegovy, and Rybelsus.

Start My Semaglutide Evaluation — $179/mo → 60-Second Quiz

✓ No insurance needed · ✓ Ships in 5-7 days · ✓ Cancel anytime

Avg weight loss

~15%

Cost

$179–1,349/mo

Dosing

Once weekly

FDA Status

Weight Loss

Semaglutide is the most-prescribed GLP-1 receptor agonist in the United States. As the active ingredient in Ozempic, Wegovy, and Rybelsus, semaglutide treats type 2 diabetes and obesity, with average weight loss of about 15% over 68 weeks at the highest dose. It is administered as a weekly injection (Ozempic, Wegovy) or daily oral pill (Rybelsus).

Overview

Semaglutide was developed by Novo Nordisk and first approved in 2017 as Ozempic for type 2 diabetes. The same molecule was approved at higher doses as Wegovy in 2021 specifically for chronic weight management. The oral tablet form (Rybelsus) was approved in 2019 for type 2 diabetes only.

Semaglutide is a 31-amino-acid peptide modeled on natural GLP-1, with structural modifications that extend its half-life from minutes to roughly 7 days. A fatty acid side chain at position 26 binds to albumin in the bloodstream, slowing renal clearance and protecting the molecule from DPP-4 enzyme breakdown.

In landmark trials (STEP-1 for weight, SUSTAIN for diabetes, SELECT for cardiovascular outcomes), semaglutide produced 14.9% average weight loss in non-diabetics, 6.0% in diabetics, and a 20% reduction in major cardiovascular events. It is now considered first-line for both type 2 diabetes and obesity in patients without contraindications.

How Semaglutide Works

Semaglutide activates GLP-1 receptors in four primary locations:

Brain (hypothalamus and brainstem): reduces appetite and food cravings
Stomach: slows gastric emptying so meals stay satisfying longer
Pancreas: increases insulin release when blood sugar is high; reduces glucagon
Heart and blood vessels: reduces inflammation and improves cardiac function (mechanism behind the SELECT trial cardiovascular benefit)

Patients typically lose 5-7% of body weight in the first 3 months and continue losing for 12-18 months at therapeutic dose, then plateau. Stopping the medication usually results in regain — about two-thirds of lost weight returns within a year.

Dosing & Schedule

Semaglutide is titrated upward over 16-20 weeks to minimize gastrointestinal side effects. Standard schedules:

Wegovy (weight loss)

Weeks 1-4: 0.25 mg/week
Weeks 5-8: 0.5 mg/week
Weeks 9-12: 1.0 mg/week
Weeks 13-16: 1.7 mg/week
Weeks 17+: 2.4 mg/week (maintenance)

Ozempic (diabetes)

Weeks 1-4: 0.25 mg/week
Weeks 5-8: 0.5 mg/week
Optional escalation to 1.0 mg or 2.0 mg if A1c remains elevated

Rybelsus (oral, diabetes)

Month 1: 3 mg daily
Month 2: 7 mg daily
Month 3+: 14 mg daily if needed
Take on empty stomach, 30 minutes before food, with no more than 4 oz water

Effectiveness — Trial Data

Trial data for semaglutide:

STEP-1 (Wegovy 2.4 mg, 68 weeks): 14.9% average weight loss vs. 2.4% placebo. About 50% of users lost ≥15%; 32% lost ≥20%.
SUSTAIN-1 to SUSTAIN-7 (Ozempic 0.5-1.0 mg): 1.5-1.8% A1c reduction; 4-6 kg average weight loss as a side benefit.
SELECT (Wegovy in cardiovascular patients): 20% reduction in major adverse cardiovascular events.
Real-world data: Average loss is somewhat lower than trial (~10-12%) due to imperfect adherence and shorter durations.

Side Effects

The most common side effects of semaglutide:

Nausea (44% in trials, decreasing over time)
Diarrhea (30%)
Vomiting (24%)
Constipation (24%)
Decreased appetite (universal — intended effect)
Fatigue (10%)
Headache (10%)

Serious but uncommon: acute pancreatitis, gallstone disease, kidney injury (often dehydration-related), retinopathy progression in diabetics, and the boxed warning for medullary thyroid carcinoma in patients with personal/family MEN 2 history. Read the full side effects guide.

Cost — How Much Semaglutide Costs in 2026

Semaglutide pricing varies enormously by route:

Wegovy list price: $1,349/mo without insurance
Ozempic list price: $998/mo without insurance
Rybelsus list price: $1,029/mo without insurance
Insurance copay (when covered): typically $25-100/mo
Compounded semaglutide via telehealth: from $179/mo all-in
NovoCare savings card: up to $200/mo off Wegovy for some commercial-insurance patients

Who Is Semaglutide For?

Semaglutide is appropriate for:

Adults with BMI ≥30 (Wegovy)
Adults with BMI ≥27 and at least one weight-related comorbidity (hypertension, dyslipidemia, type 2 diabetes, sleep apnea)
Adults with type 2 diabetes (Ozempic, Rybelsus)
Adults with established cardiovascular disease and obesity (Wegovy, expanded indication 2024)

It is contraindicated in patients with personal/family history of medullary thyroid carcinoma or MEN 2, and in pregnancy.

Semaglutide Alternatives

If semaglutide is not the right fit:

Tirzepatide — stronger weight loss (~22% vs. ~15%) but newer and more expensive
Liraglutide — older daily injection, generic available
Orforglipron — pipeline oral GLP-1 expected 2026
Contrave — non-GLP-1 oral option

Frequently Asked Questions

Is semaglutide the same as Ozempic?

Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus — three different brand names by Novo Nordisk. Ozempic is approved for type 2 diabetes; Wegovy is the same molecule at higher dose for weight loss; Rybelsus is the oral pill version.

How fast does semaglutide work?

Appetite suppression begins within 1-2 weeks. Visible weight loss starts at week 4-8 and continues for 12-18 months. Most weight is lost in the first 6 months.

Is compounded semaglutide as effective as Wegovy?

The active ingredient is the same molecule. Compounded versions vary in concentration and additives, so individual response can differ. Reputable compounding pharmacies use the same potency as branded; less reputable ones may dilute or use semaglutide salt forms with different bioavailability.

Can I switch from Ozempic to Wegovy?

Yes — they are the same molecule. Your prescriber can transition your dose: typically starting Wegovy at the equivalent or one step lower dose than your Ozempic, then titrating up.